The Regulatory Fork in the Road
While the 2024 Farm Bill's November 12 compliance deadline dominates hemp industry headlines, a quieter legislative battle is unfolding in Congress that could reshape the long-term regulatory framework for hemp products. Rep. Andy Barr (R-KY) has introduced the Lawful Hemp Protection Act, a bill that would remove hemp-derived products from FDA jurisdiction and transfer oversight authority to the Alcohol and Tobacco Tax and Trade Bureau (TTB) — the same federal agency that regulates beer, wine, and distilled spirits.
The proposal is gaining attention as one of the more structurally distinct alternatives to FDA's long-stalled hemp rulemaking, and it has implications that reach all the way to the B2B ingredient supply chain.
What the Lawful Hemp Protection Act Proposes
Barr's bill would treat hemp-derived consumable products — including beverages, tinctures, and edibles — under a regulatory structure modeled on alcohol commerce:
- TTB, not FDA, would set labeling, manufacturing, and distribution standards for hemp products
- Excise tax frameworks similar to those applied to alcohol would fund oversight and enforcement
- State-level control over retail distribution would be preserved, much like the three-tier alcohol system (producer → distributor → retailer)
- Pre-market approval requirements would be determined by TTB rulemaking rather than FDA's New Dietary Ingredient (NDI) or food additive pathways
The TTB model is appealing to some hemp industry stakeholders because TTB has decades of operational experience regulating consumable products with intoxicating potential — and because FDA's inaction on hemp has left a regulatory vacuum that states have been forced to fill inconsistently.
Why TTB Regulation Attracts Support
FDA has declined to establish a clear regulatory pathway for hemp-derived CBD and other cannabinoids since the 2018 Farm Bill legalized hemp. Despite multiple Congressional hearings, industry petitions, and bipartisan pressure, FDA has not finalized rules governing hemp as a food ingredient, dietary supplement, or beverage additive.
This vacuum has produced a patchwork of state regulations, an enforcement gray zone, and significant uncertainty for manufacturers and ingredient buyers. Supporters of the TTB model argue that:
- TTB already regulates products with psychoactive potential and has established frameworks for age restrictions, labeling requirements, and distribution controls
- The alcohol industry's supply chain infrastructure — including licensed distributors and retailers — could be adapted to hemp without building a new regulatory apparatus from scratch
- Excise taxes on hemp products would generate revenue for enforcement, unlike FDA's current resource-constrained approach
Kentucky, home to a substantial hemp farming sector, has been among the states most vocal about federal regulatory clarity — making Barr's sponsorship both politically and economically motivated.
The Complications and Opposition
Not all hemp stakeholders view the TTB model favorably. Several points of friction have emerged:
Ingredient supply chain complexity. Hemp is used as a raw material ingredient across dozens of product categories — supplements, topicals, pet products, food, beverages. A TTB framework built for finished consumable products may not translate cleanly to B2B ingredient sales, where the buyer (not the ingredient supplier) is the entity producing the finished product.
GMP and safety standards. FDA's 21 CFR Part 111 Good Manufacturing Practice framework for dietary supplements includes rigorous testing, documentation, and facility inspection requirements. It is unclear whether TTB's equivalent standards for food-grade manufacturing would be as robust, or whether hemp ingredient buyers would face a different compliance bar depending on which agency oversees their finished product.
State opt-out dynamics. The Hemp Safety Enforcement Act, introduced by Senators Paul, Klobuchar, and Ernst, already proposes a state opt-out framework. A TTB model could interact unpredictably with that structure — particularly in states that have passed their own hemp restrictions.
Industry fragmentation. Some hemp trade associations prefer FDA oversight precisely because FDA's standards are recognized internationally and would support export market access in ways that TTB regulation might not.
The November 12 Deadline Remains Unaffected
Regardless of the Lawful Hemp Protection Act's legislative trajectory — which remains uncertain in a divided Congress — the 2024 Farm Bill's compliance standards take effect on November 12, 2026. The TTB framework, if enacted at all, would govern a future regulatory structure, not the immediate compliance requirements facing hemp manufacturers and ingredient buyers today.
For B2B buyers sourcing hemp ingredients, the immediate priorities remain unchanged:
- Verify that all ingredients meet the 0.4mg total THC per container standard
- Confirm supplier testing is conducted by ISO 17025-accredited, DEA-registered laboratories
- Ensure Certificates of Analysis reflect total THC calculation (delta-9 THC + THCA × 0.877), not delta-9 alone
- Maintain documentation sufficient to demonstrate compliance under federal law
What Ingredient Suppliers Should Watch
The Lawful Hemp Protection Act is worth tracking because it signals where Congressional thinking may be heading on long-term hemp oversight. If TTB regulation gains traction, it could affect how hemp ingredient suppliers are classified, taxed, and audited — and how downstream customers structure their purchasing relationships.
For now, the practical implication for the B2B hemp ingredient market is straightforward: work with suppliers whose compliance infrastructure is built to meet federal standards — whichever agency ultimately enforces them.
